Kyle Gano, CEO: Neurocrine Biosciences NBIX Sell · Filed 25/01/17

Trade details

Type: Insider sale
Amount: $8,516,602
Shares · price: 60,188 sh · $141.50 a share
Held after: 135,392 sh
Stock: Neurocrine Biosciences NBIX
Person: Kyle GanoCEO
Trade date: 25/01/15
Filed: 25/01/17
Days to filing: 2 days

Sold 30.8% of holdings

Share of holding sold: 30.8%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 24/12/16~25/02/14

Kyle Gano's recent trades

Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$4.6M
34,588 sh
$4.6M
Filed 01/20
Traded 01/16
Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$240.5K
1,812 sh
$240.5K
Filed 01/20
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$4.9M
36,400 sh
$4.9M
Filed 01/16
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/05
Traded 25/11/04
Kyle GanoCEO
SellNeurocrine Biosciences
Sell
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/04
Traded 25/11/04